A second hypothesis centers around observations that vascular endothelial growth factor (VEGF) levels are elevated in HPS and HFRS patients, and that VEGF could affect vascular permeability by increasing the degradation of VE-cadherin [9]–[12]. This evidence concerns the gene CDH5 and Hermansky-Pudlak syndrome.